Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).
Bailey
C J
CJ
Aston University, Birmingham, UK.
D000367:Age Factors; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D008055:Lipids; D011345:Fenofibrate